These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 27679750)

  • 1. Personalized Medicine in Ocular Fibrosis: Myth or Future Biomarkers.
    Yu-Wai-Man C; Khaw PT
    Adv Wound Care (New Rochelle); 2016 Sep; 5(9):390-402. PubMed ID: 27679750
    [No Abstract]   [Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current and future prospects for the prevention of ocular fibrosis.
    Dahlmann AH; Mireskandari K; Cambrey AD; Bailly M; Khaw PT
    Ophthalmol Clin North Am; 2005 Dec; 18(4):539-59. PubMed ID: 16314218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding Drivers of Ocular Fibrosis: Current and Future Therapeutic Perspectives.
    Mallone F; Costi R; Marenco M; Plateroti R; Minni A; Attanasio G; Artico M; Lambiase A
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound Shear Wave Elastography for Liver Disease. A Critical Appraisal of the Many Actors on the Stage.
    Piscaglia F; Salvatore V; Mulazzani L; Cantisani V; Schiavone C
    Ultraschall Med; 2016 Feb; 37(1):1-5. PubMed ID: 26871407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Proteomics for biomarker development toward personalized medicine].
    Kondo T
    Rinsho Byori; 2012 Jul; 60(7):644-9. PubMed ID: 22973724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer Drug Development: New Targets for Cancer Treatment.
    Curt GA
    Oncologist; 1996; 1(3):II-III. PubMed ID: 10387987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical high-molecular-weight hyaluronan and a roofing barrier sheet equally inhibit postlaminectomy fibrosis.
    Akeson WH; Massie JB; Huang B; Giurea A; Sah R; Garfin SR; Kim CW
    Spine J; 2005; 5(2):180-90. PubMed ID: 15749618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tear analysis in ocular surface diseases.
    Zhou L; Beuerman RW
    Prog Retin Eye Res; 2012 Nov; 31(6):527-50. PubMed ID: 22732126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlating and Combining Genomic and Proteomic Assessment with In Vivo Molecular Functional Imaging: Will This Be the Future Roadmap for Personalized Cancer Management?
    Basu B; Basu S
    Cancer Biother Radiopharm; 2016 Apr; 31(3):75-84. PubMed ID: 27093341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers for personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2015 Mar; 64(3 Suppl 1):S16-21. PubMed ID: 25468140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aiming for zero blindness].
    Nakazawa T
    Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):168-93; discussion 194. PubMed ID: 25854109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer biomarkers: current issues and future directions.
    Jain KK
    Curr Opin Mol Ther; 2007 Dec; 9(6):563-71. PubMed ID: 18041667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Where are we in genomics?
    Hocquette JF
    J Physiol Pharmacol; 2005 Jun; 56 Suppl 3():37-70. PubMed ID: 16077195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalized Critical Care Medicine: How Far Away Are We?
    Ahasic AM; Christiani DC
    Semin Respir Crit Care Med; 2015 Dec; 36(6):809-22. PubMed ID: 26595041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Biomarkers on Personalized Medicine.
    Carrigan P; Krahn T
    Handb Exp Pharmacol; 2016; 232():285-311. PubMed ID: 26330258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The beginning of personalized medicine in sepsis: small steps to a bright future.
    Christaki E; Giamarellos-Bourboulis EJ
    Clin Genet; 2014 Jul; 86(1):56-61. PubMed ID: 24579691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personalized Cardiovascular Medicine Today: A Food and Drug Administration/Center for Drug Evaluation and Research Perspective.
    Blaus A; Madabushi R; Pacanowski M; Rose M; Schuck RN; Stockbridge N; Temple R; Unger EF
    Circulation; 2015 Oct; 132(15):1425-32. PubMed ID: 26459078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomics and Personalized Medicine.
    Koen N; Du Preez I; Loots du T
    Adv Protein Chem Struct Biol; 2016; 102():53-78. PubMed ID: 26827602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying novel biomarkers for cardiovascular disease risk prediction.
    Ge Y; Wang TJ
    J Intern Med; 2012 Nov; 272(5):430-9. PubMed ID: 22950687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.